Poster Abstract Session:
59. Prevention and Treatment of Viral Infections
Thursday, October 3, 2013: 12:30 PM-2:00 PM
Room: The Moscone Center: Poster Hall C


Use and Effectiveness of Neuraminidase Inhibitor Treatment of Influenza in Healthy Adults and Children in a Military Population
Mary Fairchok, MD ; John Arnold, MD ; Christina Schofield, MD FACP ; Patrick Danaher, MD ; Karl Kronmann, MD, MPH ; Michael Rajnik, MD ; Erin McDonough, BS ; Christopher Myers, PhD ; Deepika Mor, MS ; Michelande Ridore, BA ; Mark Kortepeter, MD, MPH ; Timothy Burgess, MD, MPH ; Eugene Millar, PhD

Predicting Outcomes of Rotavirus-Related Disease in Adults-Does the Modified Vesikari Score Work?
Evan J. Anderson, MD ; Jacqueline E. Tate, PhD ; Deanna Shippee, B.A. ; Melissa Davila, B.A. ; Bruce Larkin, BS ; Ben Katz, MD ; Gary Noskin, MD ; Andi L. Shane, MD, MPH, MSc ; Melissa Weinrobe, B.A. ; Ram Yogev, MD ; Umesh D. Parashar, MBBS, MPH
  • Rotavirus Severity #40935.pdf (161.1 kB)

  • 459
    Comparing Severity of Hematological Decline Across Various Hepatitis C Treatment Regimens
    Lokesh Shahani, MD, MPH ; Vikas Jogi, MD ; Isha Tyagi, MD ; Vidya Sundareshan, MD, MPH ; Shingo Chihara, MD ; Amardeep Shreshtha ; Swapna Devanna ; Dheeraj Reddy ; Srivalli Vegi, MD ; Jennifer Andoh ; Scott Bergman, Pharm, D ; Janak Koirala, MD

    Entecavir versus tenofovir in treatment-nave Chronic Hepatitis B patients: THIRD YEAR results of a Real-world Study
    Fehmi Tabak, professor ; Bilgul Mete ; Bahadir Ceylan ; Nail Ozgunes ; Alper Gunduz ; Hayat Karaosmanoglu ; Atahan Cagatay ; Kadir Gokturk ; Levent Erdem ; Funda Kocak ; Ebubekir Senates ; Resat Ozaras
  • Realist- poster.jpg (701.4 kB)

  • 461
    Prediction and its management of severe anemia in chronic hepatitis C patients treated with telaprevir-based triple therapy
    Eiichi Ogawa, MD., PhD. ; Norihiro Furusyo, MD., PhD. ; Masayuki Murata, MD., PhD. ; Hiroaki Ikezaki, MD. ; Satoshi Hiramine, MD. ; Jun Hayashi, MD., PhD.

    Telaprevir-based triple therapy for elderly patients with genotype 1 chronic hepatitis C
    Norihiro Furusyo, MD., PhD. ; Eiichi Ogawa, MD., PhD. ; Masayuki Murata, MD., PhD. ; Hiroaki Ikezaki, MD. ; Satoshi Hiramine, MD. ; Jun Hayashi, MD., PhD.
  • 2013IDweek462.pdf (179.9 kB)

  • 464
    Burden of Outpatient Illness due to Respiratory Viruses in US Preterm Infants: Findings from a Two-Year Prospective Cohort Study
    Evan J. Anderson, MD ; Eric A. F. Simoes, MB BS, DCH, MD ; Christopher S. Ambrose, MD ; Xionghua Wu, PhD ; Jessie R. Groothuis, MD

    Referral and Treatment Patterns of Hepatitis C
    Wei Boon Ooi, MD ; Fernando Madero-Gorostieta, MD ; Saurabh Dahiya, MD ; Michael Rosenblum, MD ; Alexander Knee ; Armando Paez, MD ; Daniel Skiest, MD
  • HepC.jpg (378.9 kB)

  • 467
    Natural human interferon-beta plus ribavirin treatment toleration by chronic hepatitis C patients with depression or thrombocytopenia
    Hiroaki Ikezaki, MD. ; Norihiro Furusyo, MD., PhD. ; Satoshi Hiramine, MD. ; Eiichi Ogawa, MD., PhD. ; Masayuki Murata, MD., PhD. ; Jun Hayashi, MD., PhD.
  • IDweek 2013 No467 ikezaki.pdf (275.6 kB)

  • 468
    Influenza Infection and Antiviral Treatment among Adults Hospitalized with Acute Respiratory Illness
    Angela P. Campbell, MD, MPH ; Su Su, MSc, MPH ; Marie R. Griffin, MD, MPH ; Laura Strange ; Holly A. Hill ; Lisa Kilpatrick ; H. Keipp Talbot, MD, MPH ; Mark G. Thompson, PhD ; Paul Gargiullo, PhD ; Alicia Fry, MD, MPH

    Analysis of ganciclovir resistant HHV-6Bclinical isolates by using PCR with quenching probes (QP-PCR)
    Hiroyuki Hiramatsu, MS ; Ryota Suzuki, Ph.D ; Shigeki Yamada, Ph.D ; Masaru Ihira, Ph.D. ; Yoshiki Kawamura, MD ; Erina Matsuoka, MD ; Hiroki Miura, MD ; Tetsushi Yoshikawa, MD
  • yehwz2013IDSA.png (646.6 kB)

  • 470
    Barriers to Hepatitis C Treatment in an HIV-HCV Co-Infected Cohort
    Guajira Thomas, MD ; Claudia Hawkins, MD ; Sudhir Penugonda, MD MPH ; Michael Angarone, DO ; Frank Palella, MD ; Valentina Stosor, MD

    Influence of Promandate Attitude on Influenza Vaccination Rate of Health Care Workers
    Reda Awali, MD, MPH ; Preethy Samuel, PhD ; Muhammad Bilal Asghar, MD ; Bharat Marwaha, MD ; Nazir Ahmad, MD ; Puneet Gupta, MBBS ; Vinod Kumar, MBBS ; Joseph Ellsworth ; Elaine Flanagan, BSN, MSA ; Mark Upfal, MD ; Jim Russel, MD ; Carol Kaplan ; Keith Kaye, MD, MPH, FIDSA, FSHEA ; Teena Chopra, MD, MPH
  • IDSA_Flu_Awali.pdf (425.5 kB)

  • 472
    Successful treatment of parainfluenza virus (PIV) respiratory infection with DAS181 in 3 immunocompromised children
    Alpana Waghmare, MD ; Thor Wagner, MD ; Robert Andrews, MD ; Sherilyn Smith, MD ; Jane Kuypers, PhD ; Ronald Moss, MD ; Janet A. Englund, MD, FIDSA
  • IDWeek 2013_092613.pdf (1.0 MB)

  • 473
    Functionality and Determinants of Antibody Responses to H1N1 pandemic Inactivated Vaccine (pH1N1 vaccine) in HIV-Infected Children and Youth
    Donna Curtis, MD, MPH ; Petronella Muresan, MS ; Sharon Nachman, MD ; Terence Fenton, PhD ; Kelly M. Richardson, MS ; Teresa Dominguez, MS ; Pat Flynn, MD ; George Siberry, MD, MPH ; Stephen Spector, MD ; Coleen Cunningham, MD ; Anthony Bloom, BA ; Adriana Weinberg, MD
  • NWCS114_Poster_FINAL.pdf (252.0 kB)

  • 475
    Care Seeking for RSV Disease in Preterm Infants Born at 32-35 Weeks Gestation: Findings from a Two-Year Cohort Study
    Eric A.F. Simoes, MB BS, DCH, MD ; Evan J. Anderson, MD ; Kellie Ryan, MPH ; Xionghua Wu, PhD ; Christopher Ambrose, MD

    CME Credits:

    ACPE Credits:

    ACPE Number:

    Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.